Tech giant Apple has appointed Johnson & Johnson's chief executive Alex Gorsky to its board, revealing once again its ambitions in the healthcare arena.
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS